🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amy Tiersten

Mount Sinai Hospital

ORCID: 0000-0002-4054-9140

Also affiliated with Cancer Institute (WIA), Mount Sinai Medical Center, Mount Sinai Hospital, Tisch Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination”.

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Distant metastases after diagnosis: Racial disparities in breast cancer outcomes.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1084

N/A

0DataRank · unranked

1 citations

Ilana Ramer, Justina Ray, Emily J. Gallagher, Nina A. Bickell, Amy Tiersten +1 more

Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer

Cancer(2022)10.1002/cncr.34426

N/A

0DataRank · unranked

15 citations

Malin Hovstadius, Melanie Wain Kier, Erin Moshier, Brittney S. Zimmerman, Krystal Cascetta +4 more

Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-021-06504-0

N/A

0DataRank · unranked

9 citations

Zhiqiang Li, Brittney S. Zimmerman, Marc Y. Fink, Jason D. Wells, Xiang Zhou +8 more

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report

Journal of Dermatological Treatment(2024)10.1080/09546634.2024.2336118

N/A

0DataRank · unranked

10 citations

Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb +2 more

Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07439-y

N/A

0DataRank · unranked

5 citations

Rima Patel, Emily J. Gallagher, Tianxiang Sheng, Damodara Rao Mendu, Amy Tiersten +7 more

A randomized controlled trial of hypnosis to manage musculoskeletal pain in breast cancer survivors taking aromatase inhibitors.

Psychology of Consciousness Theory Research and Practice(2024)10.1037/cns0000388

N/A

0DataRank · unranked

1 citations

Julie B. Schnur, Amy Tiersten, Kelley N. Benck, Joel Erblich, Guy H. Montgomery

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis

Cancer(2025)10.1002/cncr.35771

N/A

0DataRank · unranked

3 citations

Tianxiang Sheng, Márcio A. Diniz, Joseph A. Sparano, Amy Tiersten, Rima Patel

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04030-2

N/A

0DataRank · unranked

24 citations

Allison L. Brodsky, Joseph A. Sparano, Stephanie V. Blank, Mimi Kim, Dawn L. Hershman +6 more

Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07802-7

N/A

0DataRank · unranked

1 citations

Jami Fukui, Paula Klein, Erin Moshier, Hulya Kocyigit, Laura Fiedler +13 more